HOME › DRUGS › TOFERSEN
ACTIVE SUBSTANCE / INN

TOFERSEN

Brand name(s): QALSODY, Qalsody
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Amyotrophic Lateral Sclerosis
NDA215887
ACTIVE SUBSTANCE
Tofersen
REGULATORS
FDA · EMA
SPONSORS / MAH
Biogen Netherlands B.V. , BIOGEN MA
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
QALSODYNDA215887BIOGEN MAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
QalsodyBiogen Netherlands B.V. Authorised29/05/2024Amyotrophic Lateral Sclerosis

FULL INTELLIGENCE ON TOFERSEN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →